[1]
Ruiz, R. et al. 2024. Treatment of progressive ovarian tumors with the therapeutic combination of the AcM Nimotuzumab and the NGGM3/VSSP vaccine. BioNatura Journal: Ibero-American Journal of Biotechnology and Life Sciences. 1, 4 (Dec. 2024), 11. DOI:https://doi.org/10.70099/BJ/2024.01.04.13.